1 Reason to Buy Novavax Stock, and 3 (Better) Reasons to Sell
Like many of the biotechs pursuing coronavirus vaccine development, Novavax (NVAX -0.98%) has seen better days. Its shares are down by 96% over the past three years, and the company's remaining shareholders face fading hopes for a spontaneous revival.Nonetheless, while there are a few good arguments for why you should avoid investing, there's still one big reason to buy Novavax stock. Let's discuss the major point in its favor that might drive some to be interested in buying it, then follow up with a trio o ...